Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,833 | 193 | 87.6% |
| Education | $400.84 | 10 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $511.46 | 28 | $0 (2019) |
| ViiV Healthcare Company | $509.19 | 25 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $423.92 | 26 | $0 (2019) |
| Gilead Sciences, Inc. | $321.40 | 30 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $283.17 | 21 | $0 (2019) |
| Allergan Inc. | $199.06 | 13 | $0 (2019) |
| Janssen Biotech, Inc. | $125.72 | 12 | $0 (2019) |
| Celgene Corporation | $122.54 | 8 | $0 (2019) |
| Insmed, Inc. | $121.13 | 3 | $0 (2019) |
| Amgen Inc. | $120.17 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $21.06 | 1 | Amgen Inc. ($21.06) |
| 2019 | $1,374 | 81 | Astellas Pharma US Inc ($229.07) |
| 2018 | $975.66 | 59 | ViiV Healthcare Company ($363.94) |
| 2017 | $863.15 | 62 | Astellas Pharma US Inc ($146.15) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2020 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Inflammation | ||||||
| 12/19/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 12/03/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA, REMICADE | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Immunology | ||||||
| 11/14/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Dermatology | ||||||
| 11/12/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 11/08/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.94 | General |
| 11/07/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/05/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/05/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/29/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.77 | General |
| 10/28/2019 | Theratechnologies Inc. | EGRIFTA (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: HIV | ||||||
| 10/21/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
| 10/17/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 10/17/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: HIV | ||||||
| 10/09/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/03/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/01/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: HIV | ||||||
| 09/12/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/11/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/10/2019 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Respiratory | ||||||
| 09/10/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Respiratory | ||||||
| 09/10/2019 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $3.27 | General |
| Category: Respiratory | ||||||
| 09/05/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Immunology | ||||||
| 08/29/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/28/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
About Dr. Pablo Rodriguez, MD
Dr. Pablo Rodriguez, MD is a Infectious Disease healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609964105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pablo Rodriguez, MD has received a total of $3,233 in payments from pharmaceutical and medical device companies, with $21.06 received in 2020. These payments were reported across 203 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,833).
Practice Information
- Specialty Infectious Disease
- Location Amarillo, TX
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609964105
Products in Payments
- ACTHAR (Biological) $423.92
- TRIUMEQ (Drug) $276.20
- CRESEMBA (Drug) $217.55
- AVYCAZ (Drug) $193.51
- JULUCA (Drug) $170.33
- ZERBAXA (Drug) $142.58
- Arikayce (Drug) $121.13
- Enbrel (Biological) $120.17
- PREZCOBIX (Drug) $119.04
- ISENTRESS (Drug) $118.89
- Cresemba (Drug) $106.16
- Cimzia (Drug) $104.08
- Tymlos (Biological) $63.68
- DOVATO (Drug) $62.66
- SIMPONI ARIA (Biological) $62.21
- Uloric (Drug) $46.52
- Otezla (Drug) $40.88
- MYCAMINE (Drug) $37.78
- VIVLODEX (Drug) $35.69
- EGRIFTA (Drug) $31.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Amarillo
Joseph Carlisle, M.d, M.D
Infectious Disease — Payments: $1,830
Tarek Naguib, M.d, M.D
Infectious Disease — Payments: $1,383
Deepak Garg, Md, MD
Infectious Disease — Payments: $1,194
Dr. Flint Smith, Md, MD
Infectious Disease — Payments: $593.09
Faisal Khasawneh, M.d, M.D
Infectious Disease — Payments: $390.95
Abhijit Gutal, M.d, M.D
Infectious Disease — Payments: $217.49